1. Home
  2. NAMSW vs SQFTP Comparison

NAMSW vs SQFTP Comparison

Compare NAMSW & SQFTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMSW
  • SQFTP
  • Stock Information
  • Founded
  • NAMSW N/A
  • SQFTP N/A
  • Country
  • NAMSW Netherlands
  • SQFTP United States
  • Employees
  • NAMSW 29
  • SQFTP 15
  • Industry
  • NAMSW Biotechnology: Pharmaceutical Preparations
  • SQFTP Real Estate Investment Trusts
  • Sector
  • NAMSW Health Care
  • SQFTP Real Estate
  • Exchange
  • NAMSW Nasdaq
  • SQFTP Nasdaq
  • Market Cap
  • NAMSW N/A
  • SQFTP N/A
  • IPO Year
  • NAMSW N/A
  • SQFTP N/A
  • Fundamental
  • Price
  • NAMSW $9.00
  • SQFTP $15.64
  • Analyst Decision
  • NAMSW
  • SQFTP
  • Analyst Count
  • NAMSW 0
  • SQFTP 0
  • Target Price
  • NAMSW N/A
  • SQFTP N/A
  • AVG Volume (30 Days)
  • NAMSW N/A
  • SQFTP N/A
  • Earning Date
  • NAMSW N/A
  • SQFTP N/A
  • Dividend Yield
  • NAMSW N/A
  • SQFTP N/A
  • EPS Growth
  • NAMSW N/A
  • SQFTP N/A
  • EPS
  • NAMSW N/A
  • SQFTP N/A
  • Revenue
  • NAMSW N/A
  • SQFTP N/A
  • Revenue This Year
  • NAMSW N/A
  • SQFTP N/A
  • Revenue Next Year
  • NAMSW N/A
  • SQFTP N/A
  • P/E Ratio
  • NAMSW N/A
  • SQFTP N/A
  • Revenue Growth
  • NAMSW N/A
  • SQFTP N/A
  • 52 Week Low
  • NAMSW N/A
  • SQFTP N/A
  • 52 Week High
  • NAMSW N/A
  • SQFTP N/A
  • Technical
  • Relative Strength Index (RSI)
  • NAMSW 47.49
  • SQFTP 44.33
  • Support Level
  • NAMSW $9.40
  • SQFTP $14.50
  • Resistance Level
  • NAMSW $10.14
  • SQFTP $15.90
  • Average True Range (ATR)
  • NAMSW 0.44
  • SQFTP 0.37
  • MACD
  • NAMSW -0.12
  • SQFTP 0.04
  • Stochastic Oscillator
  • NAMSW 24.31
  • SQFTP 62.27

About NAMSW NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About SQFTP Presidio Property Trust Inc. 9.375% Series D Cumulative Redeemable Perpetual Preferred Stock $0.01 par value per share

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

Share on Social Networks: